Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease
International Immunopharmacology, ISSN: 1567-5769, Vol: 101, Issue: Pt A, Page: 108263
2021
- 5Citations
- 12Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- CrossRef4
- Captures12
- Readers12
- 12
- Mentions1
- News Mentions1
- News1
Most Recent News
Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease.
Int Immunopharmacol. 2021 Oct 29;101(Pt A):108263. Authors: Liu H, Zhou YC, Song W PubMed: 34710847 Submit Comment
Review Description
Both the total amount and annual growth rate of Alzheimer's disease (AD) patients in China are much higher than in other regions in the world. This trend of rapid growth will be difficult to change in the next few decades, hence the prevention and treatment situation of AD patients in China is more severe. Maintaining the balance between the production and removal pathways of Aβ is an important guarantee for the body to maintain its normal physiological state. The dysfunction of Aβ clearance is an important factor of Aβ accumulation in brain tissue of AD patients causing neurotoxicity of synaptic damage and neuronal death. Based on the literature review, it introduced the important role of microglias in clearing Aβ deposits in the process of Alzheimer's disease. And most of these phagocytic cells were the specific phenotype of disease-related microglia (DAM-I/DAM-II) that induced microglial differentiation after activation. IL-10KO promoted the transformation of microglial phenotype DAM-II, and enhanced its phagocytosis for Aβ oligomers. There is a hypothesis that IL-10R/STAT3 negatively regulates microglial phagocytosis. It was learnt that blocking the IL-10R/STAT3 pathway promoted microglial activation and enhanced phagocytosis. The comprehensive review on the involvement of IL-10R/STAT3 pathway in the process of AD would open up new ideas and discover new targets for the development of new therapeutic drugs.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1567576921008997; http://dx.doi.org/10.1016/j.intimp.2021.108263; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85117757256&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/34710847; https://linkinghub.elsevier.com/retrieve/pii/S1567576921008997; https://dx.doi.org/10.1016/j.intimp.2021.108263
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know